April 22, 2026 05:43 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Will never forget’: Nation remembers Pahalgam victims as leaders vow strong fight against terror | 'India will never bow to any form of terror': PM Modi on Pahalgam terror attack anniversary | TCS Nashik case: No interim bail for Danish Shaikh in religious sentiments case | US woman alleges sexual assault at Karnataka homestay; owner among 2 arrested | ‘PM Modi is a terrorist’: Mallikarjun Kharge sparks row; BJP hits back | ‘What kind of order is this?’: Mamata slams ECI’s bike curbs in poll-bound Bengal, calls it ‘mischief’ | ‘90% of women can’t do politics without entering male politicians’ rooms’: Pappu Yadav sparks row; BJP targets Congress | Tim Cook to step down as Apple CEO; John Ternus named successor | 15 killed, 20 injured as bus plunges into gorge in J&K’s Udhampur | Oil jumps over 5% as Strait of Hormuz closure fuels supply fears
Covid-19 Vaccine
Image Credit: Narendra Modi Twitter Handle

Applying for emergency use of Covid-19 vaccine in 2 weeks: Serum Institute

| @indiablooms | Nov 29, 2020, at 03:58 pm

New Delhi/IBNS: The Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.

"As of now, we don't have anything in writing with the government of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July 2021," he told reporters at a press conference.

"We are in the process of applying in the next two weeks for the emergency use," he added.

PM Modi on Saturday visited Zydus Biotech Park in Ahmedabad and Bharat Biotech facility in Hyderabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila as well as the vaccine candidate by Bharat Biotech.

"At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress," PM Modi tweeted on Saturday. He later visited the Serum Institute in Pune too.

Poonawalla said, "At the moment the trials were more than enough for the efficacy. We might look at doing trials on group less than 18 years of age later on."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.